pruritus
Showing NaN - NaN of 10
Dermatitis, Atopic, Pruritus Trial in United States (ASN008, ASN008 Matching Vehicle)
Recruiting
- Dermatitis, Atopic
- Pruritus
- ASN008
- ASN008 Matching Vehicle
-
Scottsdale, Arizona
- +17 more
May 24, 2023
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Huntsville, Alabama
- +51 more
Dec 21, 2022
Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)
Recruiting
- Pruritus
- Atopic Dermatitis
- difelikefalin 0.25 mg
- +4 more
-
Scottsdale, Arizona
- +36 more
Dec 21, 2022
Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Birmingham, Alabama
- +48 more
May 18, 2021
Pruritus, Psoriasis Trial in United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)
Completed
- Pruritus
- Psoriasis
- 5 mg Serlopitant Tablets
- Matching Placebo Tablets
-
Bryant, Arkansas
- +38 more
May 18, 2021
Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)
Terminated
- Pruritus
- +3 more
- 5 mg Serlopitant Tablets
-
Birmingham, Alabama
- +84 more
May 18, 2021
Pruritus, Atopic Dermatitis Trial in United States (Serlopitant High Dose, Placebo Oral Tablet, Serlopitant Low Dose)
Completed
- Pruritus
- Atopic Dermatitis
- Serlopitant High Dose
- +2 more
-
Anniston, Alabama
- +51 more
May 18, 2021
Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral
Completed
- Chronic Kidney Diseases
- Pruritus
- CR845 0.25 mg Oral Tablet
- +3 more
-
Birmingham, Alabama
- +59 more
Oct 22, 2020
